Dr Rodrigo Dienstmann of Vall d’Hebron University Hospital, Barcelona, Spain presented COLOSSUS at the American Association for Cancer Research (AACR) Intestinal Stem Cells and Colon Cancer: Biology to Therapy conference. The four-day meeting ran from the 27-30 September 2018 in Washington, DC, USA. Rodrigo’s talk, “Risk stratification as a basis for targeted therapy in colon cancer” was delivered on Saturday, September 29th.

As a result of emerging colon cancer research and cancer biology, opportunities abound for translation into new avenues for early detection, risk stratification, and innovative therapies (targeted therapeutics and immunotherapy). This exciting conference drew an international cohort of more than 22,500 students, fellows, scientists, physicians, industry representatives, and government officials.